Document text
MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda (Draft)
Centers for D
isease Con trol and Prevention
Atlanta, GA
Thursday, September 18, 2025
10:00 AM Welcome and Roll Call Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
10:30 AM Update on Work Groups Dr. Martin Kulldorff (ACIP Chair)
11:00 AM Measles, Mumps, Rubella, and Varicella
(MMRV) Vaccines
Introduction Dr. Martin Kulldorff (ACIP Chair)
Background on MMRV Dr. Arjun Srinivasan (CDC/NCIRD)
Presentation on febrile seizure following
MMRV vaccine Dr. John Su (CDC/NCEZID)
Proposed recommendations and discussion Dr. Martin Kulldorff (ACIP Chair)
1:00 PM Lunch
1:30 PM Hepatitis B Vaccine
Introduction Dr. Martin Kulldorff (ACIP Chair)
Presentation on Hep atitis B Birth Dose
Vaccination Dr. Adam Langer (CDC/NCHHSTP)
Hep B vaccine safety updates Dr. John Su (CDC/NCEZID)
Proposed recommendations and discussion Dr. Martin Kulldorff (ACIP Chair)
4:00 PM Break
4:15 PM Agency Updates CDC, CMS, FDA, HRSA, IHS, NIH
4:30 PM Public Comment
5:00 PM Votes
MMRV vaccines Dr. Martin Kulldorff (ACIP Chair)
MMRV vaccines - VFC Dr. Jeanne Santoli (CDC/NCIRD)
Hepatitis B vaccines Dr. Martin Kulldorff (ACIP Chair)
Hepatitis B vaccines – VFC Dr. Jeanne Santoli (CDC/NCIRD)
5:30 PM Adjourn
MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)
Agenda (Draft)
Friday, September 19, 2025
8:30 AM Welcome and Roll Call Dr. Martin Kulldorff (ACIP Chair)
Dr. Mina Zadeh (ACIP Executive Secretary, CDC)
8:45 AM COVID -19 Vaccines
Introduction Dr. Retsef Levi (ACIP WG Chair)
COVID -19 epidemiology update Dr. Arjun Srinivasan (CDC/NCIRD)
Updates to 2024 -2025 COVID -19 Implementation
Considerations Dr. Arjun Srinivasan (CDC/NCIRD)
COVID -19 vaccine effectiveness update Dr. Arjun Srinivasan (CDC/NCIRD)
COVID -19 vaccine safety update Dr. John Su (CDC/NCEZID)
Additional COVID -19 vaccine safety presentations TBD
11:30 AM Lunch
12:00 PM COVID -19 Vaccines (continued)
Economic analysis of COVID -19 vaccination Dr. Arjun Srinivasan (CDC/NCIRD) on behalf of
the University of Michigan
COVID -19 Vaccine Manufacturer update s TBD
COVID -19 Discussion Framing Dr. Retsef Levi (ACIP WG Chair)
Proposed recommendations and discussion Dr. Retsef Levi (ACIP WG Chair)
1:40 PM Break
1:45 PM Public Comment
2:15 PM Votes
COVID -19 Vaccines Dr. Retsef Levi (ACIP WG Chair)
3:00 PM Adjourn